<i>In silico</i> development of potential InhA inhibitors through 3D-QSAR analysis, virtual screening and molecular dynamics.

导出 LinkOut

翻译打印收藏纠错

第一作者： Vaishnav,Bhaskar

第一单位： Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

作者： Vaishnav,Bhaskar ^[1] ; Sunil,Kumar ^[1] ; Aathira,Sujathan Nair ^[2] ; S,Gokul ^[1] ; Prayaga,Rajappan Krishnendu ^[1] ; Sonu,Benny ^[1] ; C T,Amrutha ^[1] ; Deepthi S,Manisha ^[1] ; Vaishnavi,Bhaskar ^[3] ; Subin,Mary Zachariah ^[1] ; T P,Aneesh ^[1] ; Mohamed A,Abdelgawad ^[4] ; Mohammed M,Ghoneim ^[5] ; Leena K,Pappachen ^[1] ; Orazio,Nicolotti ^[6] ; Bijo,Mathew ^[1]

作者单位： Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India. ^[1] School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia. ^[2] Department of Electronics and Computer Engineering, Amrita Vishwa Vidyapeetham, Kollam, Kerala, India. ^[3] Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf university, Sakaka, Saudi Arabia.;Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. ^[4] Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah, Saudi Arabia. ^[5] Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Bari, Italy. ^[6]

关键词 3D QSAR InhA Tuberculosis inhibitor mycolic acid